Acarix USA, Inc.

251 West 30th Street, 5th Floor
New York,  NY  10001

United States
  • Booth: FH11

CADScor®System NOW AVAILABLE IN THE US Acarix USA, Inc brings innovative AI-based technology to assess patients with chronic chest-pain to help rule out Coronary Artery Disease (CAD) in less than 10 minutes with 96% confidence. With FDA DeNovo clearance and CPTIII listing, CADScor®System is now launching in the United States. COME VISIT US AT FUTURE HUB BOOTH FH11.

 Additional Info

ACC.22 Learning Pathways? (select all that apply)
Ischemic Heart Disease